The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Aims Acute coronary syndromes (ACS) are mostly caused by plaque rupture. This study
aims to investigate the prognostic value of in vivo detection of high-risk coronary plaques by …

Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

Background Everolimus-eluting and paclitaxel-eluting stents, compared with bare metal
stents, reduced the risk of restenosis in clinical trials with strict inclusion and exclusion …

Background Recent reports have indicated that there may be an increased risk of late stent
thrombosis with the use of drug-eluting stents, as compared with bare-metal stents. Methods …

At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation
of a stent, often a drug-eluting stent, though most published data originated in the era of bare …

Background—Although drug-eluting stents (DES) significantly reduce restenosis, they
require 3 to 6 months of thienopyridine therapy to prevent stent thrombosis. The rate and …

Background Drug-eluting stents with durable biocompatible or biodegradable polymers
have been developed to address the risk of thrombosis associated with first-generation drug …

BACKGROUND: Changes in the treatment of coronary artery disease both surgically and
percutaneously have rendered the major randomized trials historical. Furthermore, the …